You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.


Evolving Strategies in Peripheral Artery Disease Post-Revascularization: Insights for the Vascular Team

  • Authors: Marc Bonaca, MD, MPH; Daniella Kadian-Dodov, MD
  • CME / ABIM MOC / CE Released: 8/24/2022
  • Valid for credit through: 8/24/2023, 11:59 PM EST
Start Activity

Target Audience and Goal Statement

This educational activity is intended for vascular medicine specialists, vascular surgeons, cardiologists, primary care physicians, nurses, pharmacists, and other healthcare professionals involved in the management of patients with peripheral artery disease (PAD).

The goal of this activity is that learners will be better able to treat patients with dual antithrombotic pathway inhibition therapy in patients with PAD post-revascularization.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • The interprofessional approaches in educating patients on modifiable cardiovascular risk factors
  • Have greater competence related to
    • The use of antithrombotic therapy in patients with PAD following lower-extremity revascularization


Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.


  • Marc Bonaca, MD, MPH

    Executive Director
    CPC Clinical Research
    Professor of Medicine
    Director of Vascular Research
    University of Colorado School of Medicine
    Aurora, Colorado


    Marc Bonaca, MD, MPH, has the following relevant financial relationships:
    Research funding from: Abbott; Agios; Alexion Pharma; Alnylam; Amgen; Angionetics; Anthos Therapeutics; ARCA Biopharma; Array; AstraZeneca; Atentiv; Audentes; Bayer; Better Therapeutics; Bristol Myers Squibb; Cardiol Therapeutics; CellResearch; Cook Medical; Cook Regentec; CSL Behring; Eidos Therapeutics; EP Trading Co; Epizon Pharma; Esperion Therapeutics; Faraday; Fortress Biotech; HDL Therapeutics; Hummingbird Bioscience; Insmed; Janssen; Kowa Research; Lexicon; Medtronic; Merck; Moderna; Novate Medical; NovoNordisk; Pfizer; PhaseBio; PPD Development; Prothena Biosciences; Regeneron; Regio Biosciences; Sanifit Therapeutics; Sanofi; Silence Therapeutics; Stealth BioTherapeutics; VarmX; Wraser
    Owns stock (publicly traded) in: Medtronic; Pfizer

  • Daniella Kadian-Dodov, MD

    Assistant Professor of Medicine, Cardiology
    Icahn School of Medicine
    Mount Sinai Medical Center
    New York, New York


    Daniella Kadian-Dodov, MD, has the following relevant financial relationships:
    Speaker or member of speakers bureau for: Abbott


  • Anne M. Sendaydiego, PharmD

    Medical Education Director, WebMD Global, LLC 


    Anne M. Sendaydiego, PharmD, has no relevant financial relationships.  

Compliance Reviewer/Nurse Planner

  • Lisa Simani, APRN, MS, ACNP

    Associate Director, Accreditation and Compliance, Medscape, LLC


    Lisa Simani, APRN, MS, ACNP, has no relevant financial relationships.

Accreditation Statements

Developed through a collaboration between Society for Vascular Medicine and Medscape Education.


Interprofessional Continuing Education

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit for learning and change.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

    For Nurses

  • Awarded 0.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.25 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.


Evolving Strategies in Peripheral Artery Disease Post-Revascularization: Insights for the Vascular Team

Authors: Marc Bonaca, MD, MPH; Daniella Kadian-Dodov, MDFaculty and Disclosures

CME / ABIM MOC / CE Released: 8/24/2022

Valid for credit through: 8/24/2023, 11:59 PM EST


Educational Impact Challenge

The goal of this activity is that learners will be better able to treat patients with dual antithrombotic pathway inhibition therapy in patients with PAD post-revascularization.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

  • Print